This article provides a 2014 update on the developmental history, current status, and future advancements of transcatheter aortic valve implantation for high-risk patients with severe aortic stenosis.
2014 TAVI review offers historical context only; leaves open questions on post-2014 outcomes, devices, and guidelines.
There is a growing trend for high‐risk patients with severe aortic stenosis who are denied open heart surgery to undergo transcatheter aortic valve implantation ( TAVI ). Since its invention more than two decades ago, TAVI has evolved rapidly from the proof‐of‐concept phase to become an established Food and Drug Administration‐approved technology. This article reviews the developmental histories and current status, as well as the future advancement of the technique. Answer questions and earn CME: https://www.wileyhealthlearning.com/Activity2/3707283/Activity.aspx
No takes yet. Share an insight, caveat, or question.
Phang et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: